QualityStocksNewsBreaks Archives - Page 710 of 1421

WednesdayApr 14, 2021 10:20 am

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) Enters Agreement to Develop Global Entertainment and Music Artist Driven, NFTs

Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, has signed a letter of intent (“LOI”) with Santo Blockchain Labs and Santo Mining Corp (OTC: SANP) for the development of non-fungible tokens (“NFTs”) and Fanpasscrypto. The agreement calls for Santo to develop global entertainment and music artist driven non-fungible tokens along with Friendable’s own marketplace, called Fanpasscrypto, which will be an exciting addition to the FDBL’s current artist and marketing offering. The announcement noted that each NFT represents a unique opportunity for new revenue streams for the…

WednesdayApr 14, 2021 10:19 am

QualityStocksNewsBreaks – Augusta Gold Corp. (TSX: G) (OTCQB: AUGG) (FSE: 11B) Appoints Donald Taylor as President and CEO

Augusta Gold (TSX: G) (OTCQB: AUGG) (FSE: 11B) today announced its appointment of Donald Taylor, currently serving as a director of the company, as its president and chief executive officer, effective immediately. Maryse Belanger has resigned as CEO, president and a director of Augusta Gold for personal reasons. Taylor, currently chief executive officer of Titan Mining Corporation, has extensive experience spanning 30 years in mineral exploration with precious and base metals on five continents, taking projects from exploration to mine development. He is the recipient of the Prospectors and Developers Association of Canada's 2018 Thayer Lindsley Award for the 2014…

WednesdayApr 14, 2021 10:07 am

QualityStocksNewsBreaks – Hemptown Organic Corp. Announces Strategic Engagement with Leading Digital Marketing Firm, Hawke Media

Hemptown, one of the nation’s leading cultivators of feminized hemp, has announced a a strategic move to modernize its e-commerce model and drive marketing solutions. The company, along with its wholly owned subsidiary Kirtman Group, has entered into a engagement with Hawke Media. Hawke Media is a leading, Los Angeles-based, digital marketing firm. The partnership is designed to combine cutting-edge cannabinoid products with customized, performance-driven marketing solutions and will enhance Hemptown’s direct-to-consumer sales via e-commerce channels. The announcement noted that Hawke will focus on implementing a results-driven multimedia strategy and elevating both the Hemptown and Kirkman brands through a variety…

WednesdayApr 14, 2021 9:53 am

QualityStocksNewsBreaks – Asia Broadband Inc. (AABB) Announces Planned Legal Action to Fight Misleading Internet Posts

Asia Broadband (OTC: AABB), a resource company focused on the production, supply and sale of precious and base metals primarily to Asian markets, plans to take legal action against posts made on the internet. The company announced that it is taking action against numerous misleading and defamatory internet statements posted on various public platforms and websites; those posts have been made over the past several months. The announcement included an example of recent post that appeared to be a press release referencing a letter of intent with New World Gold Corp.; however the information was not submitted by or authorized…

WednesdayApr 14, 2021 9:44 am

QualityStocksNewsBreaks – TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Shares Research Study Findings Showing Strong Product Reception

TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has announced notable findings from a recent market research study that focused on the TAAT concept, brand image and product-user experience. The two-part market research study was conducted by Toronto-based market research firm Burak Jacobson Partners Inc. among smokers aged 21 years and older living in Ohio, Michigan, Illinois and Pennsylvania. Highlights of the study included more than half of the respondents stated that they definitely would or probably would purchase TAAT products, with more than 28% of those responding definitely would citing the retail price of the product. In addition,…

WednesdayApr 14, 2021 9:16 am

QualityStocksNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Announces Receipt of Developmental Order for Cryogenic Probe Head

AmpliTech Group (NASDAQ: AMPG, AMPGW), a designer, developer, and manufacturer of custom and standard state-of-the-art RF (“RF”) components for commercial, SATCOM, 5G, quantum computing, space, defense and military markets, has received a developmental order for its exclusive cryogenic probe head; the order was received from Amplify My Probe Ltd. The cryogenic device, which uses AmpliTech's innovative cryogenic low-noise amplifier technology, is designed for use in the study of materials, molecules and drugs for the treatment of diseases. A spin out from the Quantum Spin Dynamics group at the London Centre for Nanotechnology and UCLQAmplify, My Probe commercializes technology to improve the signal-to-noise…

WednesdayApr 14, 2021 8:30 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Intent to Proceed with Strategic Acquisition, Enter Global Eco-Friendly Agrochemicals Market

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions, today announced it has finalized terms and executed a new letter of intent to purchase the assets of an internationally based developer and supplier of organically natural, eco-friendly agrochemicals. According to the update, the acquisition allows PBI to enter the agrochemicals market with sought-after alternatives to synthetic pesticides and fertilizers serving the rapidly growing sectors of organic and environmentally sustainable agricultural production worldwide. “As previously announced, upon completion, this acquisition of assets will establish PBI with a portfolio…

TuesdayApr 13, 2021 4:13 pm

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Announces Participation in H.C. Wainwright Mining Conference, Featured in Streetwise Reports Article

Uranium Energy (NYSE American: UEC) has announced that it will be a featured presenting company at the upcoming H.C. Wainwright Spring Mining Conference, slated for April 19–20, 2021. UEC CEO Amir Adnani will present at the virtual event. His live presentation is scheduled for Monday, April 19, at 10 a.m. ET. Adnani will also be available to participate in one-on-one meetings with investors attending the conference. An archived presentation will be available on EUC’s website for 90 days after the conference. In addition, Adnani talks about the company’s business play and objectives in a recent Streetwise Reports article, noting that…

TuesdayApr 13, 2021 3:28 pm

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Issues Operational Update

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has provided a comprehensive operational update. Among the many highlights, the company announced that it ranks as second in the U.S. for CBD brand awareness according to the Brightfield Group and that, according to SPINS, Probulin Probiotics finished 2020 as the fastest-growing probiotic brand out of the top 10 in the U.S. “The company has built a strong foundation throughout a challenging 2020. After the completion of a successful IPO, the company remains focused on executing its five-channel…

TuesdayApr 13, 2021 2:29 pm

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Enters Agreement for Upcoming Phase 1b/2a Clinical Trial

AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, nonsystemic therapies for gastrointestinal (“GI”) diseases, has entered into an agreement with PPD Inc. (NASDAQ: PPD) for its upcoming phase 1b/2a clinical trial. PPD, a leading global contract research organization will manage the clinical trial using both oral immediate-release tablet and topical rectal enema foam formulations of micronized oral niclosamide, or FW-420 (“CRO”). The trial is designed to evaluate proprietary formulations of micronized niclosamide for grade 1 colitis and diarrhea in oncology patients receiving treatment with immune checkpoint inhibitors (“ICIs”). This is the second clinical trial involving niclosamide that the…

Site Search

Company Search

Category: QualityStocksNewsBreaks